The Online Investor
OLI Premium
Retiree Portfolio
Stock Option Ideas
Preferred Stock List

Slideshow IPOs

By The Online Investor Staff, updated Fri., Feb. 12, 9:22 PM

Slide #1. Proteostasis Therapeutics, Inc. Initial Public Offering

Company: Proteostasis Therapeutics, Inc.
Proposed Symbol: PTI
Shares Offered: 6,250,000
Price Per Share: $8.00
Over-Allotment: 937,500
Description: Proteostasis Therapeutics, Inc. today announced the pricing of its initial public offering of 6,250,000 shares of common stock at a public offering price of $8.00 per share, before underwriting discounts and commissions. All of the common stock is being offered by Proteostasis Therapeutics, Inc. In addition, the company has granted the underwriters a 30-day option to purchase up to an additional 937,500 shares of common stock from the company at the public offering price. The company's shares are expected to begin trading on the NASDAQ Global Market on February 11, 2016 under the ticker symbol "PTI." The offering is expected to close on February 17, 2016 subject to customary closing conditions.

IPOs: Proteostasis Therapeutics, Inc.

List of IPOs in this Slideshow:
Company                                 Ticker    IPO Date
Instructure                             INST      
Mesoblast Limited                       MESO      
Mimecast Limited                        MIME      
Match Group, Inc.                       MTCH      
Square, Inc.                            SQ        
Duluth Holdings Inc.                    DLTH      
Kitov Pharmaceuticals Holdings Ltd.     KTOV      
Atlassian                               TEAM      
Yirendai Ltd.                           YRD       
China Customer Relations Centers, Inc.  CCRC      
Advanced Disposal Services, Inc.        ADSW      
BeiGene, Ltd.                           BGNE      
Editas Medicine, Inc.                   EDIT      
AveXis, Inc.                            AVXS      
Proteostasis Therapeutics, Inc.         PTI       

February 12, 2016    9:22 PM Eastern

IPOs | | Copyright © 1998 - 2016, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.